These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32229155)

  • 1. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
    Das UN
    Arch Med Res; 2020 Apr; 51(3):282-286. PubMed ID: 32229155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections.
    Das UN
    Arch Med Sci; 2023; 19(5):1327-1359. PubMed ID: 37732033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review.
    Das UN
    J Adv Res; 2018 May; 11():57-66. PubMed ID: 30034876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19.
    Rogero MM; Leão MC; Santana TM; Pimentel MVMB; Carlini GCG; da Silveira TFF; Gonçalves RC; Castro IA
    Free Radic Biol Med; 2020 Aug; 156():190-199. PubMed ID: 32653511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
    Das UN
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32825011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive Lipids in COVID-19-Further Evidence.
    Das UN
    Arch Med Res; 2021 Jan; 52(1):107-120. PubMed ID: 32981754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
    Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
    Front Immunol; 2020; 11():1997. PubMed ID: 32983141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19.
    Ghaffari S; Roshanravan N; Tutunchi H; Ostadrahimi A; Pouraghaei M; Kafil B
    Arch Med Res; 2020 Jul; 51(5):464-467. PubMed ID: 32327293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 10. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 12. Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution.
    Das UN
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus.
    Xu P; Sun GD; Li ZZ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5797-5809. PubMed ID: 32495918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19).
    Naeem U; Naeem A; Naeem MA; Naeem K; Mujtaba B; Mujtaba A; Khurshid A
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9172-9181. PubMed ID: 32965011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
    Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
    Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
    Vargas M; Servillo G; Einav S
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
    Welch SR; Davies KA; Buczkowski H; Hettiarachchi N; Green N; Arnold U; Jones M; Hannah MJ; Evans R; Burton C; Burton JE; Guiver M; Cane PA; Woodford N; Bruce CB; Roberts ADG; Killip MJ
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32839250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia.
    Das UN
    Nutrition; 2015 Sep; 31(9):1083-95. PubMed ID: 26233865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.
    Pastorino B; Touret F; Gilles M; Luciani L; de Lamballerie X; Charrel RN
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32521706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.